维普中文期刊产品整合服务
41篇 您的检索式:作者名="Negri AL"
    题名 作者 年代 出处 被引量
1Clinical and biochemical profile of patients with 'pure' uric acid nephrolithiasis compared with'pure' calcium oxalate stone formers显示文摘Negri AL Spivacow R Del Valle E 2007Urol Res2007,35,5:1
2Citrate and renal stones显示文摘del Valle EE Spivacow FR Negri AL 2013Medicina (B Aires)2013,73,:1
3Fibrohlast growth factor 23:associations with cardio- vascular disease and mortality in chronic kidney disease显示文摘Negri AL 2013Int Urol Nephrol2013,0,:1
4Clinical andmetabolic risk factor evaluation in young adults with kidney stones显示文摘Spivacow FR Negri AL del Valle EE 2010Int Urol Nephrol2010,42,2:1
5Calcitriol resistance in hemodialy- sis patients with secondary Hyperparathyroidism 显示文摘Negri AL Brandemburg VM 2014Int Urol Nephrol2014,46,:1
6Proanthocyanidins and the risk of colorectal cancer in Italy 显示文摘MARTA ROSSI EVA NEGRI MARIA PARPINEL et al 2010Cancer Causes Control2010,,21:1
7Clinical and metabolic risk factor evaluation in young adults with kidney stones显示文摘Spivacow FR Negri AL del Valle EE 2009Int Urol Nephrol2009,42,2:1
8Prevalence of 25(0H) vitamin D insufficiency and deficiency in chronic kidney dis- ease stage 5 patienta on hemodialysis显示文摘Del Valle E Negri AL Aguirre C 2007Hemodial Int2007,11,3:1
9Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers 显示文摘Negri AL Spivacow FR Del Valle EE 2008Urol Res2008,36,6:1
10Prevention of progressive fibrosis in chronic renal diseases : Antifibrotic agents显示文摘Negri AL 2004J Nephrol2004,17,4:1
11Vascular calcification in chronic kidney dis- ease:are these new treatments 显示文摘NEGRI AL 2005Curt Vasc Phamacol2005,3,2:1
12Prevention of progressive fibrosis in chronic renal diseases : antifibrotic agents 显示文摘Negri AL 2004J Nephrol2004,17,4:1
13The klotho gene: a gene predominantly expressed in the kidney is a fundamental regulator of aging and calcium/ phosphorus metabolism显示文摘Negri AL 2004Journal of Nephrology2004,18,6:1
14The klotho gene: a gene predominantly expressed in the kidney is a fundamental regulator of aging and calciuml phosphorus metabolism显示文摘Negri AL 2005J Nephrol2005,18,6:1
15Prevention of progressive fibrosis in chronic renal diseases: antifihrotic agents显示文摘Negri AL 2004J Nephrol2004,17,4:1
16Role of overweight and obesity on the urinary excretion of promoters and inhibitiors of stone formation in stone formers显示文摘Negri AL Spivacow FR Del Valle EE 2008Urol Res2008,36,6:1
17Prevention of progressive fibrosis in chronic renal diseases: antifibrotic agents 显示文摘Negri AL 2004J Nephol2004,17,4:1
18Biomeohanieal background for a noninvasive assessment of bone strength and musclebone interactions显示文摘Cointry GR Capozza RF Negri AL 2004J Museuloskelet Neuronal Interact2004,4,1:1
19Fibroblast growth factor 23:Associations with cardiovascular disease and mortality in chronic kidney disease显示文摘Negri AL 2014Int Urol Nephrol2014,46,1:1
20Comparative pharmacokinetics of a single oral dose of two formulations of amlodipine : a randomized, single-blind, two-period, two-sequence, crossover study显示文摘PICO JC DOMINGUEZ G NEGRI AL 2008Arzneimittelforschung2008,58,7:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费